MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
Medcura
Attachments
Medcura
Parents
*Architects: Blood Processing, Blood Pumps, Diagnostics, Hemorrhage, Bleeding, Hemostatis, Transfusion, Intravenous (IV) Management
*Architects: Trauma, Blood, Wound Healing, Military Medicine, Combat Casualty Care & Emergency Medicine
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
Children
▪ LifeFoam™ under development as a breakthrough device for internal traumatic and military injuries
▪ Rapid-Seal® becoming a market leader in high-performance, antibacterial first aid
2021: Medcura raises $7.4 Million to Expand FDA-Approved Line of Hemostatic and Wound Treatment Products
and ▪ LifeGel™ under development for use during routine surgery.
Larry Tiffany is Chief Executive Officer and Director of Medcura (2021)
Matthew Dowling, Ph.D. is Chief Scientific Officer and Director of Medcura (2021)
Medcura quickly stops bleeding using an inert, self-assembling biopolymer that has been cleared by the FDA for multiple applications
Medcure products include:
Riverdale, Maryland